{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:31:41Z","timestamp":1791117101725,"version":"4.1.0"},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\u2018Splenic red pulp lymphoma with numerous basophilic villous lymphocytes\u2019 (SRPL), recently described, is characterized by clinical, morphologic, immunologic, cytogenetic and molecular features distinct from SMZL\/SLVL and HCL. In particular, the intensity of CD11c staining (expressed as fluorescence intensity \u2010RFI\u2010) in SRPL is significantly different from the RFI in SMZL\/SLVL and HCL. Moreover the use of a scoring system based on the expression of CD11c, CD22, CD76, CD38 and CD27 appears to improve the differential diagnosis between SRPL and SMZL\/SLVL and emphasizes that SRPL is an entity closed to but distinct from SMZL\/SLVL. Copyright \u00a9 2010 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.957","type":"journal-article","created":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T01:05:41Z","timestamp":1280451941000},"page":"47-51","source":"Crossref","is-referenced-by-count":47,"title":["Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B\u2010cell lymphoma (SRPL)"],"prefix":"10.1002","volume":"29","author":[{"given":"L.","family":"Baseggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Traverse\u2010Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Callet\u2010Bauchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Magaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Felman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-098848"},{"key":"e_1_2_5_3_2","first-page":"191","volume-title":"World Health Organisation Classification of Tumours Haemaopoietic and Lymphoid Tisues","author":"Piris M","year":"2008"},{"key":"e_1_2_5_4_2","first-page":"185","volume-title":"World Health Organisation Classification of Tumours Haemaopoietic and Lymphoid Tisues","author":"Isaacson PG","year":"2008"},{"key":"e_1_2_5_5_2","first-page":"188","volume-title":"World Health Organisation Classification of Tumours Haemaopoietic and Lymphoid Tisues","author":"Foucar K","year":"2008"},{"key":"e_1_2_5_6_2","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B\u2010cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes E","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_5_7_2","first-page":"303","article-title":"The diagnostic value of CD123 in B\u2010cell disorders with hairy or villous lymphocytes","volume":"89","author":"Del Giudice I","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/32.2.6198355"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009057637"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.957","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T19:39:24Z","timestamp":1700595564000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1002\/hon.957"],"URL":"https:\/\/doi.org\/10.1002\/hon.957","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}